Showing results (531-540 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|June 28, 2015
AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) In VivoRicardo Ribas, Sunil Pancholi, Stephanie K Guest, et al.
Molecular Cancer Therapeutics|July 5, 2015
Heat Shock Protein 90 Is a Potential Therapeutic Target in CholangiocarcinomaTomoki Shirota, Hidenori Ojima, Nobuyoshi Hiraoka, et al.
Molecular Cancer Therapeutics|July 5, 2015
Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck CancersChunrong Li, Shyhmin Huang, Eric A Armstrong, et al.
Molecular Cancer Therapeutics|July 5, 2015
CDK1-Mediated SIRT3 Activation Enhances Mitochondrial Function and Tumor RadioresistanceRui Liu, Ming Fan, Demet Candas, et al.
Molecular Cancer Therapeutics|May 28, 2015
MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule InhibitorYu Xiao, Paul Nimmer, George S Sheppard, et al.
Molecular Cancer Therapeutics|May 31, 2015
Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid LeukemiaZhiyong Liao, Lei Gu, Jenny Vergalli, et al.
Molecular Cancer Therapeutics|June 17, 2015
Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast CancerYeon-Jin Kwon, Kevin Petrie, Boris A Leibovitch, et al.
Molecular Cancer Therapeutics|August 12, 2016
BPR1J373, an Oral Multiple Tyrosine Kinase Inhibitor, Targets c-KIT for the Treatment of c-KIT-Driven Myeloid LeukemiaLi-Tzong Chen, Chiung-Tong Chen, Weir-Torn Jiaang, et al.
Molecular Cancer Therapeutics|July 29, 2016
Biodistribution and Targeting of Anti-5T4 Antibody-Drug Conjugate Using Fluorescence Molecular TomographyAnand Giddabasappa, Vijay R Gupta, Rand Norberg, et al.
Molecular Cancer Therapeutics|July 29, 2016
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant OsteosarcomaIlaria Buondonno, Elena Gazzano, Sae Rin Jean, et al.
Pageof 599